Coridon Pty Ltd
Company history and goals
Coridon Pty Ltd was founded in 2000 as a private unlisted company, to develop and commercialise patented technology for improving immune responses to polynucleotide vaccines licensed from the University of Queensland by the founder inventor Prof Ian Frazer. The company has laboratories within the Translational Research Institute at the Princess Alexandra Hospital in Brisbane, working in collaboration with the University of Queensland Diamantina Institute.
The company’s overall objective is to utilise its unique optimisation technology to produce prophylactic and/or therapeutic polynucleotide vaccines for a range of infectious diseases and cancers in humans. Product development is currently focused on herpesvirus vaccines.